Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;91:84-90

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alison, J. F.
Right arrow Articles by Kerr, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alison, J. F.
Right arrow Articles by Kerr, C. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ATROPINE

(Circulation. 1995;91:84-90.)
© 1995 American Heart Association, Inc.


Articles

Characterization of Junctional Rhythm After Atrioventricular Node Ablation

Jeffrey F. Alison, MBBS, FRACP; John A. Yeung-Lai-Wah, MBChB FRCPC, FACC; Michael Schulzer, MD, PhD; Charles R. Kerr, MD FRCPC, FACC

From the Department of Medicine (J.F.A., J.A.Y.L.W., C.R.K.), Division of Cardiology and Departments of Medicine and Statistics (M.S.), University of British Columbia, Vancouver, Canada.

Background Catheter ablation of the atrioventricular (AV) node with radiofrequency current (RFC) is associated with the short-term onset of a junctional escape rhythm (JER) in nearly all patients. However, the origin of the JER and short-term thermal effects of RFC on this junctional pacemaker activity are ill defined.

Methods and Results Short-term and noninvasive long-term follow-up studies were performed to examine the electrophysiological characteristics of the underlying JER in 45 patients who had undergone AV nodal ablation with RFC. Baseline characteristics and responses to overdrive ventricular pacing and intravenous atropine followed by an incremental isoproterenol infusion were determined. Short- and long-term responses were compared. HV intervals before and after ablation were 49±9 and 48±9 milliseconds, respectively (P=NS). Follow-up was 11±8.3 months. JER cycle length was 1526±298 milliseconds in the short-term setting and was present in 44 patients (98%) in the long-term setting, measuring 1426±223 milliseconds (P<.005). Junctional recovery times increased exponentially as overdrive pacing rates increased–there was no difference between short-term and long-term responses. Drug responses within each study were all significant when compared with baseline. However, there was no significant difference between short- and long-term responses, except at the highest dose of isoproterenol. Intravenous atropine (1 mg) caused an 8.6±9.3% decrease in JER cycle length in the short-term setting compared with a 7.6±7.3% decrease in the long-term setting. The decreases in JER cycle length with isoproterenol infusion (short-term versus long-term) were 10.1±9.6% versus 9.6±7.4% with 1 µg/min, 15.8±11.7% versus 17.4±8.5% with 2 µg/min, 17.9±11.2% versus 21.4±9.1% with 3 µg/min (all P=NS), and 20.6±12.1% versus 24.8±9.1% with 4 µg/min (P<.01).

Conclusions Radiofrequency ablation of the AV node is associated with development of a JER that is stable in the long-term setting. The lack of change in HV interval after ablation locates the junctional pacemaker proximal to the central fibrous body. The pattern of drug responses suggests an origin within the proximal His bundle at its junction with the AV node rather than the AV node itself. The overall similarity between short- and long-term characteristics of junctional pacemaker activity mitigates against any reversible thermal effects of RFC on this pacemaker focus.


Key Words: atrioventricular node • pacemakers • catheter ablation




This article has been cited by other articles:


Home page
EuropaceHome page
E. Occhetta, M. Bortnik, G. Dell'Era, F. Zardo, E. Dametto, B. Sassone, L. Gabrieli, and P. Marino
Evaluation of pacemaker dependence in patients on ablate and pace therapy for atrial fibrillation
Europace, December 1, 2007; 9(12): 1119 - 1123.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
D. Prabhakaran and S. S Anand
The metabolic syndrome: an emerging risk state for cardiovascular disease
Vascular Medicine, February 1, 2004; 9(1): 55 - 68.
[Abstract] [PDF]